Efficacy News and Research

RSS
DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

Magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment

Magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Green tea extract enhances cognitive functions in brain

Green tea extract enhances cognitive functions in brain

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Researchers use ultrasound to destroy cancerous tissue in brain

Researchers use ultrasound to destroy cancerous tissue in brain

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

OncoSec Medical to re-launch Phase II cutaneous T-cell lymphoma trial under protocol amendment

OncoSec Medical to re-launch Phase II cutaneous T-cell lymphoma trial under protocol amendment

Merck KGaA initiates Phase 3 START2 study of MUC1 antigen-specific cancer immunotherapy tecemotide

Merck KGaA initiates Phase 3 START2 study of MUC1 antigen-specific cancer immunotherapy tecemotide

Santen announces Phase III results of sirolimus intravitreal injections in non-infectious posterior segment uveitis patients

Santen announces Phase III results of sirolimus intravitreal injections in non-infectious posterior segment uveitis patients

A novel device for inhalation drug delivery

A novel device for inhalation drug delivery

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

FDA approves expanded use Dyax’s KALBITOR in treatment of acute hereditary angioedema

FDA approves expanded use Dyax’s KALBITOR in treatment of acute hereditary angioedema

Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

Janssen begins Phase 3 OPTIMIST trials for treatment of chronic Genotype 1 HCV infection

Janssen begins Phase 3 OPTIMIST trials for treatment of chronic Genotype 1 HCV infection

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.